Kidney Cancer Weekly

June 29, 2026

Videos

Peer-to-Peer Clinical Conversations

Phase I Trial Explores Formulation of CBM588 Probiotic in Advanced RCC - Miguel Zugman

Miguel Zugman presents phase I dose escalation results testing refrigerated capsule formulation of CBM588 probiotic with nivolumab/ipilimumab in 12 first-line metastatic clear cell renal cell carcinoma patients.

View

KIM-1 Biomarker Evaluated for Association with Outcomes in Advanced RCC Treatment - Wenxin Xu

Wenxin Xu

Pedro Barata hosts Wenxin Xu to discuss KIM-1 as a biomarker for kidney cancer based on correlative analysis from the COSMIC-313 trial.

View

Beyond the Abstracts

Mapping Heterogeneity in the Tumor Microenvironment of Renal Cell Carcinoma Through Single-Cell Omics - Beyond the Abstract

Unraveling Smooth Muscle-Rich Renal Cell Carcinoma: Clinical, Oncological, Genetic, and Pathological Insights - Beyond the Abstract

Conference Coverage

ASCO 2026: Ultrasensitive ctDNA Detection and Molecular Clearance as a Prognostic and Predictive Marker in Advanced RCC

ASCO 2026: AI-Augmented Analysis of Quantitative ctDNA Burden and Longitudinal Kinetics to Identify Prognostic Risk Stratification in Metastatic Clear Cell RCC

ASCO 2026: Microbial Dysbiosis as Predictor of Benefit from CBM588 as an Adjunct to Immune Checkpoint Blockade-Based First Line Therapies in Metastatic RCC

AUA 2026: Comparison between IO–IO and IO–TKI Combination Therapies for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus

SES AUA 2026: Impact of Cytoreductive Nephrectomy for RCC with Tumor Thrombus: Results from the Intercontinental Collaboration of RCC

Articles

Editor Selected Abstracts and Commentaries

Renal Cancer

Renal Cell Carcinoma of Native Kidneys in Kidney Allograft Recipients: Are There Any Guidelines for Management?

Oligometastatic RCC: Challenges and Emerging Therapeutic Strategies.

Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.

Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.

Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study.

Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23Na-MRI at 3 T.

Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma.

Co-design of a pre-surgical care intervention to support people undergoing prostatectomy for prostate cancer.

Real-World Comparison of the Effectiveness and Safety of Immune-Based Combinations in Elderly Patients with Advanced Renal Cell Carcinoma (ARON-1 Study) - Beyond the Abstract

Imaging modality, incidental detection, and age-stage distribution in surgically treated clear cell renal cell carcinoma.

Targeting RELA and STAT3 regulates TNFRSF10A-mediated apoptosis in a novel apoptosis-based prognostic model for clear cell renal cell carcinoma.

The Heterogeneity of B Cells Potentially Contributes to Metastasis of Clear Cell Renal Cell Carcinomas.

Preoperative MRI Model for Predicting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma with Tumor Thrombus.

CONNECT WITH US

Questions or Comments? Email us at

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Kidney Cancer Weekly

Renal Cancer

Login